Education Program for Patients Receiving Oral Anticoagulation
- Conditions
- Cardiovascular DiseaseVenous ThrombosesAtrial FibrillationBlood Coagulation Disorders, Inherited
- Registration Number
- NCT01339611
- Lead Sponsor
- University of Sao Paulo
- Brief Summary
The aim of the study is to test if patients under oral anticoagulation therapy who are going to participate in the education program will have better Health-related quality of life, higher rate in pharmacological treatment adherence and better self efficacy to manage the treatment.
- Detailed Description
Patients who are going to use oral anticoagulant will participate in an individual orientation, using instructional material (slides and illustrative booklet) during hospitalization period. After the discharge 2 phone calls will be done (after: a week and four weeks) focusing on the strategies to improve patient's self-efficacy to manage the oral anticoagulation. There will be a personal contact among researcher and participants when the patients return at the oral anticoagulant ambulatory, two months after the treatment start. At this time the following variables of interest will be evaluated: Health-related quality of life; adherence to treatment and patients' self-efficacy.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 160
- Patients admitted in two public hospitals, in São Paulo state interior and who are going to start the use of oral anticoagulant during this hospitalization
- Patients admitted in two public hospitals, in São Paulo state interior and who are going to adjust therapeutically oral anticoagulant dosage or to start over treatment.
- Individuals who do not at all have any ability to understand the data collection instrument questions, measured by the instrument Mental State Mini-exam.
- Individuals who do not have a telephone to be contacted after hospital discharge;
- Individuals who are going to metallic valve prosthesis implant surgery in the last six months.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Change from Baseline in health-related quality of life at 2 months baseline (hospitalization time) and two months after discahrge the health-related quality of life will be measure by Duke Anticoagulation Satisfaction Scale
- Secondary Outcome Measures
Name Time Method change from baseline in oral anticoagulation treatment adherence at 2 months baseline (hospitalization time) and two months after discahrge Treatment adhrence will be measure by on specif scale
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Hospital Estadual de Ribeirão Preto
🇧🇷Ribeirão Preto, São Paulo, Brazil
Hospital Estadual de Ribeirão Preto🇧🇷Ribeirão Preto, São Paulo, BrazilFlavia M Pelegrino, RNContact16 36023402flavia-martineli@bol.com.brInaiara S Corbi, RNContact16 36023402inaenf@yahoo.comRosana S Dantas, PhDPrincipal Investigator
